Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)

Gabriel Rinnerthaler; Simon Peter Gampenrieder; Andreas Petzer; Michael Hubalek; Edgar Petru; Margit Sandholzer; J. Andel; Marija Balic; Thomas Melchardt; Clemens Schmitt; et al.

doi:10.1177/17588359211042301

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)

Gabriel Rinnerthaler
, Simon Peter Gampenrieder
, Andreas Petzer
, Michael Hubalek
, Edgar Petru
, Margit Sandholzer
, J. Andel
, Marija Balic
, Thomas Melchardt
, Clemens Schmitt
, et al.

Department of Internal Medicine 3 - Hematology and Internal Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	1
Journal	Therapeutic Advances in Medical Oncology
Volume	13
DOIs	https://doi.org/10.1177/17588359211042301
Publication status	Published - Oct 2021

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/17588359211042301

Cite this

Rinnerthaler, G., Gampenrieder, S. P., Petzer, A., Hubalek, M., Petru, E., Sandholzer, M., Andel, J., Balic, M., Melchardt, T., Schmitt, C., & et al. (2021). Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6). Therapeutic Advances in Medical Oncology, 13. https://doi.org/10.1177/17588359211042301

@article{cac85a80dc2c4431809068b9d6777dcd,

title = "Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)",

author = "Gabriel Rinnerthaler and Gampenrieder, \{Simon Peter\} and Andreas Petzer and Michael Hubalek and Edgar Petru and Margit Sandholzer and J. Andel and Marija Balic and Thomas Melchardt and Clemens Schmitt and \{et al.\}",

year = "2021",

month = oct,

doi = "10.1177/17588359211042301",

language = "English",

volume = "13",

journal = "Therapeutic Advances in Medical Oncology",

issn = "1758-8359",

}

Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Hubalek, M, Petru, E, Sandholzer, M, Andel, J, Balic, M, Melchardt, T, Schmitt, C & et al. 2021, 'Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)', Therapeutic Advances in Medical Oncology, vol. 13. https://doi.org/10.1177/17588359211042301

TY - JOUR

T1 - Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)

AU - Rinnerthaler, Gabriel

AU - Gampenrieder, Simon Peter

AU - Petzer, Andreas

AU - Hubalek, Michael

AU - Petru, Edgar

AU - Sandholzer, Margit

AU - Andel, J.

AU - Balic, Marija

AU - Melchardt, Thomas

AU - Schmitt, Clemens

AU - et al., null

PY - 2021/10

Y1 - 2021/10

UR - https://www.scopus.com/pages/publications/85117187831

U2 - 10.1177/17588359211042301

DO - 10.1177/17588359211042301

M3 - Article

C2 - 34691243

SN - 1758-8359

VL - 13

JO - Therapeutic Advances in Medical Oncology

JF - Therapeutic Advances in Medical Oncology

ER -

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this